An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.

Also called NCT03216564

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03216564
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Qatar (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03216564. Randomized; single masking; primary purpose treatment. Start 2017-05-10 (actual); primary completion 2019-05-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes
Acronym
IDEAL-2
Condition
Diabetic Nephropathies
Intervention (Drug)
Calcitriol
Lead sponsor
Hamad Medical Corporation (class: industry)
Collaborator
Weill Cornell Medical College in Qatar (class: other)

Record details

Record id
cardio:ct-nct03216564
Content hash
51dada19d5929b0440fc6eaadd0fb49053f0fc748a9b06e522d3c04c18d8d5be